Cardiac Involvement in Patients with Multisystem Inflammatory Syndrome in Children (MIS-C) in Poland
暂无分享,去创建一个
[1] A. Šedivá,et al. Pathogenesis, immunology, and immune‐targeted management of the multisystem inflammatory syndrome in children (MIS‐C) or pediatric inflammatory multisystem syndrome (PIMS): EAACI Position Paper , 2023, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[2] Belma Yaşar,et al. Cardiac Evaluation in Children with Multisystem Inflammatory Syndrome Associated with SARS-CoV-2 , 2022, Sisli Etfal Hastanesi tip bulteni.
[3] B. McCrindle,et al. Differentiation of COVID-19–Associated Multisystem Inflammatory Syndrome From Kawasaki Disease With the Use of Cardiac Biomarkers , 2022, The Canadian Journal of Cardiology.
[4] T. Kuno,et al. Longitudinal Cardiac Outcomes of Multisystem Inflammatory Syndrome in Children: A Systematic Review and Meta-Analysis , 2022, Pediatric Cardiology.
[5] Michelle R Santoso,et al. Cardiovascular Magnetic Resonance in Children with Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: Institutional Protocol-Based Medium-Term Follow-up Study , 2022, Pediatric Cardiology.
[6] M. Oster,et al. Comparison of Multisystem Inflammatory Syndrome in Children–Related Myocarditis, Classic Viral Myocarditis, and COVID‐19 Vaccine‐Related Myocarditis in Children , 2022, Journal of the American Heart Association.
[7] M. Gattorno,et al. Cardiovascular Manifestations in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19 According to Age , 2022, Children.
[8] V. Calcaterra,et al. Cardiac dysfunction in Multisystem Inflammatory Syndrome in Children: An Italian single-center study , 2022, Italian Journal of Pediatrics.
[9] A. Boutten,et al. Multisystem inflammatory syndrome in children: inputs of BNP, NT-proBNP and Galectin-3. , 2022, Clinica chimica acta; international journal of clinical chemistry.
[10] M. Oster,et al. Cardiac Magnetic Resonance Findings After Multisystem Inflammatory Syndrome in Children. , 2022, The Journal of pediatrics.
[11] K. Ludwikowska,et al. Takotsubo syndrome as a cardiac manifestation of multisystem inflammatory syndrome in children. , 2021, Cardiology in the young.
[12] M. Zaniew,et al. Distinct characteristics of multisystem inflammatory syndrome in children in Poland , 2021, Scientific Reports.
[13] P. Ponikowski,et al. Heart failure in COVID‐19: the multicentre, multinational PCHF‐COVICAV registry , 2021, ESC heart failure.
[14] R. Friedman,et al. Six Month Follow-up of Patients With Multi-System Inflammatory Syndrome in Children , 2021, Pediatrics.
[15] Kanwal M. Farooqi,et al. Longitudinal Outcomes for Multisystem Inflammatory Syndrome in Children , 2021, Pediatrics.
[16] A. Hadash,et al. Emergency department levels of NT-proBNP and inotropic/vasoactive support in multi-inflammatory syndrome in children (MIS-C) , 2021, The American Journal of Emergency Medicine.
[17] Manish M Patel,et al. Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2 , 2021, JAMA network open.
[18] M. Oster,et al. Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study , 2021, The Lancet Child & Adolescent Health.
[19] P. Brodin. Immune determinants of COVID-19 disease presentation and severity , 2021, Nature Medicine.
[20] M. Cunningham,et al. Multisystem Inflammatory Syndrome in Children (MIS-C), a Post-viral Myocarditis and Systemic Vasculitis—A Critical Review of Its Pathogenesis and Treatment , 2020, Frontiers in Pediatrics.
[21] D. De Wolf,et al. Acute Cardiovascular Manifestations in 286 Children with Multisystem Inflammatory Syndrome Associated with COVID-19 Infection in Europe. , 2020, Circulation.
[22] C. Newton-Cheh,et al. Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection — United Kingdom and United States, March–August 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[23] J. Glickstein,et al. Role of a Pediatric Cardiologist in the COVID-19 Pandemic , 2020, Pediatric Cardiology.
[24] K. Wilson,et al. Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C) , 2020, Cell.
[25] D. Buonsenso,et al. Pediatric Inflammatory Multisystem Syndrome Temporally Related With SARS-CoV-2: Immunological Similarities With Acute Rheumatic Fever and Toxic Shock Syndrome , 2020, Frontiers in Pediatrics.
[26] J. Rossano,et al. Echocardiographic Findings in Pediatric Multisystem Inflammatory Syndrome Associated With COVID-19 in the United States , 2020, Journal of the American College of Cardiology.
[27] B. Totapally,et al. Takotsubo cardiomyopathy in children , 2020, Cardiology in the Young.
[28] A. Piantadosi,et al. A young adult with COVID-19 and multisystem inflammatory syndrome in children (MIS-C)-like illness: a case report , 2020, BMC Infectious Diseases.
[29] J. Newburger,et al. Review of Cardiac Involvement in Multisystem Inflammatory Syndrome in Children. , 2020, Circulation.
[30] K. Reilly,et al. COVID-19–Associated Multisystem Inflammatory Syndrome in Children — United States, March–July 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[31] R. Loomba,et al. COVID-19 and Hyperinflammatory Syndrome in Children: Kawasaki Disease with Macrophage Activation Syndrome in Disguise? , 2020, Cureus.
[32] P. Kirchhof,et al. Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases. , 2020, JAMA cardiology.
[33] P. Ponikowski,et al. Cardiac emergencies during the COVID-19 pandemic in the light of the current evidence. , 2020, Kardiologia polska.
[34] P. Palma,et al. The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19 , 2020, Cell.
[35] P. Davies,et al. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study , 2020, The Lancet Child & Adolescent Health.
[36] D. Thacker. Multisystem Inflammatory Syndrome in Children (MIS-C): , 2020, Delaware journal of public health.
[37] Simon Li,et al. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents , 2020, The New England journal of medicine.
[38] P. Kahn,et al. COVID-19 associated Kawasaki-like multisystem inflammatory disease in an adult , 2020, The American Journal of Emergency Medicine.
[39] Jun Ren,et al. SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management , 2020, Biochemical Pharmacology.
[40] E. Blondiaux,et al. Cardiac MRI of Children with Multisystem Inflammatory Syndrome (MIS-C) Associated with COVID-19: Case Series , 2020, Radiology.
[41] P. Davies,et al. Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. , 2020, JAMA.
[42] V. Reddy,et al. Takotsubo Cardiomyopathy in COVID-19 , 2020, Journal of the American College of Cardiology.
[43] C. Delacourt,et al. SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[44] L. Bonnemains,et al. Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic , 2020, Circulation.
[45] Angelo Mazza,et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study , 2020, The Lancet.
[46] Eun Ji Kim,et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. , 2020, JAMA.
[47] G. Passalacqua,et al. Takotsubo Syndrome Associated with COVID-19 , 2020, European journal of case reports in internal medicine.
[48] Mohammad Madjid,et al. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. , 2020, JAMA cardiology.
[49] Roberto Maroldi,et al. Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). , 2020, JAMA cardiology.
[50] Tao Guo,et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) , 2020, JAMA cardiology.
[51] W. Gong,et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. , 2020, JAMA cardiology.
[52] Yiwu Zhou,et al. SARS-CoV-2: a potential novel etiology of fulminant myocarditis , 2020, Herz.
[53] Jiyuan Zhang,et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome , 2020, The Lancet Respiratory Medicine.
[54] M. Biteker,et al. Takotsubo (stress) cardiomyopathy in childhood , 2019, European Journal of Pediatrics.
[55] B. McCrindle,et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association , 2017, Circulation.
[56] H. Pan,et al. Polish 2010 growth references for school-aged children and adolescents , 2010, European Journal of Pediatrics.
[57] Nagib Dahdah,et al. New equations and a critical appraisal of coronary artery Z scores in healthy children. , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[58] K. Shadan,et al. Available online: , 2012 .